New investor Fresenius Medical Care Ventures GmbH is leading a Series B financing round in ExThera Medical Corp. to help fund clinical trials in Germany and the US of the latter’s Seraph Microbind affinity blood filter.
The Martinez, California company announced the financing, which includes an equity investment by Fresenius, on June 2